Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge represents Apax Partners LLP in connection with the acquisition of stakes in Unilabs
Mandate

Vinge represents Apax Partners LLP in connection with the acquisition of stakes in Unilabs

December 16, 2016 M&A

Vinge, together with Simpson Thacher & Bartlett LLP, represents Apax Partners LLP in connection with the divestment by private equity funds Nordic Capital Fund VI and Apax France VII of their respective stakes in Unilabs to Apax IX, advised by Apax Partners LLP.

Unilabs is with over 5,300 employees and 112 laboratories one of Europe’s leading medical diagnostics businesses. Unilabs generated annual revenues of €673 million in 2015.

The transaction is subject to regulatory approvals and the financial terms of the transaction are not being disclosed.

The Vinge team includes partner Jonas Johansson together with, among others, Alex Miler and Rasmus Perdahl.

Related

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026

Vinge advises on the sale of Compab to Tången

 Vinge has advised the owners of Compab Energiteknik in connection with the sale of 80 per cent of the shares to Tången Industrikapital. Compab, which has a turnover of approximately SEK 100 million, sells, installs and services, amongst other things, steam and hot-water boilers as well as burners for the industrial sector.
October 26, 2026